Studies in other tumor types have identified various molecules found in the TME and expressed by tumor cells that inhibit DC activation and drive DCs toward an immunosuppressive, regulatory phenotype, including vascular endothelial growth factor (VEGF), prostaglandin E2 (PGE2), IL-10, and CSF-1 [86,87,88]. This evidence concerns the gene VEGFA and neoplasm.